These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 38004264)

  • 21. Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome.
    Lejman-Larysz K; Golara A; Baranowska M; Kozłowski M; Guzik P; Szydłowska I; Nawrocka-Rutkowska J; Sowińska-Przepiera E; Cymbaluk-Płoska A; Brodowska A
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
    Fusco A; Bianchi A; Mancini A; Milardi D; Giampietro A; Cimino V; Porcelli T; Romualdi D; Guido M; Lanzone A; Pontecorvi A; De Marinis L
    J Endocrinol Invest; 2007 Dec; 30(11):948-56. PubMed ID: 18250617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of prolactin levels on MPV in women with PCOS.
    Yilmaz Ö; Calan M; Kume T; Temur M; Yesil P; Senses MY
    Clin Endocrinol (Oxf); 2015 May; 82(5):747-52. PubMed ID: 25359296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges.
    Liu YN; Qin Y; Wu B; Peng H; Li M; Luo H; Liu LL
    Reprod Toxicol; 2022 Aug; 111():11-19. PubMed ID: 35562068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
    Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.
    Paoletti AM; Cagnacci A; Soldani R; Orrù M; Ajossa S; Pittorra G; Mulas P; Melis GB
    Fertil Steril; 1995 Dec; 64(6):1094-8. PubMed ID: 7589658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevation of markers of endotoxemia in women with polycystic ovary syndrome.
    Banaszewska B; Siakowska M; Chudzicka-Strugala I; Chang RJ; Pawelczyk L; Zwozdziak B; Spaczynski R; Duleba AJ
    Hum Reprod; 2020 Oct; 35(10):2303-2311. PubMed ID: 32869098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
    Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
    Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Syndrome in Hyperprolactinemia.
    Andersen M; Glintborg D
    Front Horm Res; 2018; 49():29-47. PubMed ID: 29894997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine and metabolic characteristics in polycystic ovary syndrome.
    Glintborg D
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prolactin receptor gene (PRLR) is linked and associated with the risk of polycystic ovarian syndrome.
    Amin M; Gragnoli C
    J Ovarian Res; 2023 Nov; 16(1):222. PubMed ID: 37993904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance.
    Herman R; Sikonja J; Jensterle M; Janez A; Dolzan V
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should Subclinical Hypothyroidism Be an Exclusion Criterion for the Diagnosis of Polycystic Ovary Syndrome?
    de-Medeiros SF; Yamamoto MMW; de-Medeiros MAS; Barbosa JS; Norman RJ
    J Reprod Infertil; 2017; 18(2):242-250. PubMed ID: 28868249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.